Overview
- On Saturday, November 14, 2026, INSP analysis put adult diabetes prevalence at about 17 percent, meaning more than 14 million people in Mexico live with diabetes and roughly one in three do not know it.
- The Secretaría de Salud reported 34,104 hospital admissions for type 2 diabetes from January through September 2026 and identified infections and diabetic foot as leading causes of those admissions.
- Clinical guidance is shifting from sole glucose control to multisystem protection of the heart, kidneys and liver, with earlier use of therapies when patients are at high risk of complications.
- New treatments and technologies, including GLP‑1 receptor agonists/co‑agonists, SGLT2 inhibitors, oral semaglutide and continuous glucose monitors, can improve weight, glucose and cardiorenal outcomes but remain costly and inconsistently covered.
- Specialists call for wider early detection, family‑centered prevention for children and stronger primary care and surveillance to close the diagnosis gap and reduce future hospitalizations and complications.